BP
GILD icon

Banyan Partners’s Gilead Sciences GILD Stock Holding History

Banyan Partners’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		$9.03M Sell
84,854
-6,968
-8% -$682K 0.77% 35
2014
Q2 		$7.61M Sell
91,822
-35,375
-28% -$2.75M 0.64% 37
2014
Q1 		$9.01M Sell
127,197
-53,069
-29% -$4.16M 0.78% 34
2013
Q4 		$13.5M Buy
180,266
+4,418
+3% +$308K 0.95% 16
2013
Q3 		$11.1M Buy
175,848
+7,015
+4% +$419K 0.98% 17
2013
Q2 		$8.66M Buy
+168,833
New +$8.8M 1.7% 10

Other funds holding GILD

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Banyan Partners's GILD Position: Q3 2014 in Review

Banyan Partners reduced its Gilead Sciences (GILD) stake by 7.6% in Q3 2014, selling an estimated $682K and leaving 84,854 shares worth $9.03M. The position accounts for 0.77% of the portfolio, ranked #35.

Banyan Partners first reported a position in GILD in Q2 2013 and has held it in 6 quarters since. The position peaked at $13.5M in Q4 2013. 1,326 funds tracked by Wall St. Rank hold GILD as of Q3 2014.

  • Banyan Partners held 84,854 shares of Gilead Sciences worth $9.03M as of Q3 2014.
  • Banyan Partners sold 6,968 Gilead Sciences shares in Q3 2014, an estimated $682K.
  • Gilead Sciences made up 0.77% of Banyan Partners's portfolio in Q3 2014, its #35 holding.
  • Banyan Partners first reported a position in Gilead Sciences in Q2 2013 and has held it in 6 quarters since.
  • Banyan Partners's Gilead Sciences position peaked at $13.5M in Q4 2013.
  • 1,326 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2014.

Based on Banyan Partners's 13F filing for Q3 2014, filed 14 Nov 2014.